Retatrutide (LY3437943, developed by Eli Lilly) is a triple hormone receptor agonist, activating GLP-1, GIP, and glucagon receptors simultaneously
It turns out that quick weight loss solutions could come at a high cost to your mental health
Ozempic-like weight loss drugs may help the heart recover after a heart attack Date: March 4, 2026 Source: University of Bristol Summary: Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds
Even if the pill looks like it could be divided, it cannot
Collectively, our findings in this study elucidated the potential signaling mechanisms underlying SEMA-mediated bloodbrain barrier protection and angiogenesis promotion, highlighting its potential as a TBI therapeutic targeting vascular homeostasis